Experimental design of the Effects of Dehydroepiandrosterone in Pulmonary Hypertension (EDIPHY) trial

Pulmonary arterial hypertension (PAH) remains life-limiting despite numerous approved vasodilator therapies. Right ventricular (RV) function determines outcome in PAH but no treatments directly target RV adaptation. PAH is more common in women, yet women have better RV function and survival as compa...

Full description

Bibliographic Details
Main Authors: Thomas P. Walsh, Grayson L. Baird, Michael K. Atalay, Saurabh Agarwal, Daniel Arcuri, James R. Klinger, Christopher J. Mullin, Heather Morreo, Brynn Normandin, Sruti Shiva, Mary Whittenhall, Corey E. Ventetuolo
Format: Article
Language:English
Published: SAGE Publishing 2021-05-01
Series:Pulmonary Circulation
Online Access:https://doi.org/10.1177/2045894021989554